4//SEC Filing
Honig Peter 4
Accession 0001209191-17-045599
CIK 0001382911other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 7:38 PM ET
Size
5.6 KB
Accession
0001209191-17-045599
Insider Transaction Report
Form 4
Honig Peter
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-07-14+5,000→ 5,000 totalExercise: $2.88Exp: 2027-07-13→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 14, 2017, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date, and subject to the terms of the Stock Option Agreement in the event of a change in control of the Issuer.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001484780
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 7:38 PM ET
- Size
- 5.6 KB